Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET

被引:0
|
作者
Park, Yong-Jin [1 ]
Moon, So Young [2 ]
Yoon, Joon-Kee [1 ]
Lee, Su-Jin [1 ]
An, Young-Sil [1 ,3 ]
机构
[1] Ajou Univ, Dept Nucl Med & Mol Imaging, Sch Med, Suwon, South Korea
[2] Ajou Univ, Dept Neurol, Sch Med, Suwon, South Korea
[3] Ajou Univ, Sch Med, Dept Nucl Med & Mol Imaging, 206 World Cup Ro, Suwon 16499, Gyeonggi Do, South Korea
来源
EJNMMI RESEARCH | 2025年 / 15卷 / 01期
关键词
Amyloid; Positron emission tomography; Flutemetamol; Cutoff; CortexID suite; VALIDATION;
D O I
10.1186/s13550-024-01193-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background This study aimed to establish the optimal cutoff values for visual amyloid positivity using standardized uptake value ratios (SUVRs) in [F-18]flutemetamol (FMM) positron emission tomography (PET) imaging. Given the variability in amyloid assessment, our goal was to determine cutoff values that enhance diagnostic accuracy and assist clinicians in reliably identifying amyloid positivity. Results The identified cutoff values for visual amyloid positivity were > 1.6 for the cerebellar gray matter, > 1.38 for the whole cerebellum, and > 0.63 for the pons, yielding high sensitivity (95.5%, 94.5%, and 95.8%, respectively) and specificity (91.2%, 94.3%, and 95.2%, respectively). Conclusions The SUVR cutoff values demonstrated excellent diagnostic performance, supporting their clinical use in assessing visual amyloid positivity in [F-18]FMM PET imaging.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings
    Friederike Völter
    Leonie Beyer
    Florian Eckenweber
    Maximilian Scheifele
    Ngoc Bui
    Marianne Patt
    Henryk Barthel
    Sabrina Katzdobler
    Carla Palleis
    Nicolai Franzmeier
    Johannes Levin
    Robert Perneczky
    Boris-Stephan Rauchmann
    Osama Sabri
    Jimin Hong
    Paul Cumming
    Axel Rominger
    Kuangyu Shi
    Peter Bartenstein
    Matthias Brendel
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1384 - 1394
  • [22] Amyloid Targeting Tracer [18F]flutemetamol is Accumulated in Atherosclerotic Plaques
    Hellberg, S. E.
    Saraste, A.
    Silvola, J. M. U.
    Eskola, O.
    Liljenback, H.
    Laine, J.
    Lehikoinen, P.
    Saukko, P.
    Horkko, S.
    Knuuti, J.
    Roivainen, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S251 - S252
  • [23] Author Correction: Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments
    Soo Hyun Cho
    Yeong Sim Choe
    Young Ju Kim
    Byungju Lee
    Hee Jin Kim
    Hyemin Jang
    Jun Pyo Kim
    Young Hee Jung
    Soo-Jong Kim
    Byeong C. Kim
    Gill Farrar
    Duk L. Na
    Seung Hwan Moon
    Sang Won Seo
    Scientific Reports, 11
  • [24] Optimization of penalization function in Bayesian penalized likelihood reconstruction algorithm for [18F]flutemetamol amyloid PET images
    Fukuda, Shohei
    Wagatsuma, Kei
    Miwa, Kenta
    Yakushiji, Yu
    Kamitaka, Yuto
    Yamao, Tensho
    Miyaji, Noriaki
    Ishii, Kenji
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2024, 47 (04) : 1627 - 1637
  • [25] Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β- amyloid PET brain images
    Buckley, Christopher J.
    Sherwin, Paul F.
    Smith, Adrian P. L.
    Wolber, Jan
    Weick, Sharon M.
    Brooks, David J.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (03) : 234 - 241
  • [26] Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
    Hugh G. Pemberton
    Christopher Buckley
    Mark Battle
    Ariane Bollack
    Vrajesh Patel
    Petya Tomova
    David Cooke
    Will Balhorn
    Katherine Hegedorn
    Johan Lilja
    Christine Brand
    Gill Farrar
    EJNMMI Research, 13
  • [27] Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
    Pemberton, Hugh G. G.
    Buckley, Christopher
    Battle, Mark
    Bollack, Ariane
    Patel, Vrajesh
    Tomova, Petya
    Cooke, David
    Balhorn, Will
    Hegedorn, Katherine
    Lilja, Johan
    Brand, Christine
    Farrar, Gill
    EJNMMI RESEARCH, 2023, 13 (01)
  • [28] A deep learning model for generating [18F]FDG PET Images from early-phase [18F]Florbetapir and [18F]Flutemetamol PET images
    Sanaat, Amirhossein
    Boccalini, Cecilia
    Mathoux, Gregory
    Perani, Daniela
    Frisoni, Giovanni B.
    Haller, Sven
    Montandon, Marie-Louise
    Rodriguez, Cristelle
    Giannakopoulos, Panteleimon
    Garibotto, Valentina
    Zaidi, Habib
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (12) : 3518 - 3531
  • [29] Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology
    Beach, Thomas G.
    Thal, Dietmar Rudolf
    Zanette, Michelle
    Smith, Adrian
    Buckley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 (03) : 863 - 873
  • [30] Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
    Fiona Heeman
    Maqsood Yaqub
    Isadora Lopes Alves
    Kerstin Heurling
    Johannes Berkhof
    Juan Domingo Gispert
    Santiago Bullich
    Christopher Foley
    Adriaan A. Lammertsma
    EJNMMI Research, 9